News

AAOS Launches Orthobiologics Registry to Enhance Knee Treatments

AAOS Launches Orthobiologics Registry to Enhance Knee Treatments

AAOS Launches Orthobiologics Registry to Enhance Knee Treatments

The American Academy of Orthopaedic Surgeons (AAOS) recently unveiled an innovative initiative with the introduction of the AAOS Orthobiologics Registry (OBR). This registry aims to gather crucial evidence on the effectiveness, safety, and long-term outcomes of orthobiologic therapies for individuals diagnosed with knee osteoarthritis.

With approximately 32.5 million American adults experiencing knee osteoarthritis, the financial burden on the healthcare system is significant, with annual costs exceeding $65 billion. This stark reality underscores the necessity for comprehensive and reliable data related to emerging treatment options. Orthobiologics therapies, including platelet-rich plasma (PRP) injections, have gained traction as viable alternatives to more traditional treatments, yet the data supporting their efficacy is still developing.

Dr. Jason Dragoo, chair of the AAOS OBR and member of the AAOS Committee on Devices, Biologics and Technology, emphasized, "The need for factual information on the effectiveness of orthobiologics is paramount. Our goal with this registry is to identify which patients will benefit most from these therapies and in what contexts, ensuring that orthopedic surgeons can deliver the highest standard of quality care to those suffering from knee osteoarthritis."

Filling the Evidence Gap

The establishment of the OBR aligns perfectly with AAOS's mission to enhance musculoskeletal care through practices based on solid evidence. Although there is an increasing interest in orthobiologics among patients, current guidelines recognize the urgent need for further investigation into their application. While existing studies on PRP treatments have yielded positive results in some patient outcomes, they often suffer from limitations such as inconsistency in reporting and insufficient long-term follow-up data.

Dr. Dragoo also noted, "As interest in regenerative therapies rises due to their potential for tissue regeneration and pain alleviation, the AAOS acknowledges the necessity for credible, evidence-based sources. The OBR is designed to help distinguish between factual scientific evidence and mere speculation, ultimately ensuring that patients can access the best possible care founded on data-driven conclusions."

Registry Features and Goals

Key elements of the OBR include a patient-centric design that emphasizes data integrity and long-term monitoring of patient-reported outcomes. Unique features of the registry consist of:

  • A research-oriented registry structure with informed patient consent
  • Centralized follow-up for tracking patient-reported outcomes (PROMs)
  • Collaboration with biological sample analysis efforts
  • Integration of standardized analytical methodology
  • Stringent adherence protocols for high-quality data collection

This registry represents a strategic partnership between AAOS and leading organizations such as Elimu Informatics and PatientIQ. These partnerships ensure that the OBR is built on a robust technical and analytical framework, enhancing data reliability and accessibility.

Focused on Data-Driven Solutions

With an ongoing commitment to improving surgical and treatment practices, AAOS's initiatives aim to foster an environment where informed decision-making based on robust data is standard. In 2019, the Academy committed to investing in biologics research and development. This initiative supports the creation of unbiased information through the AAOS Biologics Dashboard and fosters educational contributions to guide orthopedic professionals and their patients.

As our population ages and obesity rates rise, there is an increasing demand for innovative treatment solutions for knee osteoarthritis. Recent data indicates that over 18% of individuals aged 55 and older struggle with this condition, revealing the extensive social and physical implications it holds. The launch of the AAOS OBR is a timely step in addressing these challenges head-on.

To explore how biologics can enhance treatment for musculoskeletal concerns, patients and healthcare providers can engage with the resources available through AAOS. Furthermore, anyone interested in learning more about the OBR or scheduling discussions regarding this initiative should reach out to AAOS directly.

Frequently Asked Questions

What is the AAOS Orthobiologics Registry?

The AAOS Orthobiologics Registry (OBR) is focused on collecting comprehensive data regarding the safety and efficacy of orthobiologic therapies for knee osteoarthritis.

Why was the OBR established?

The OBR was established to fill gaps in evidence and provide orthopedic surgeons with reliable data to improve patient care and treatment outcomes for knee osteoarthritis.

Who will participate in the OBR?

The OBR will initially involve 10 participating sites, with plans for gradual expansion to gather diverse data over the next few years.

How does the OBR contribute to patient care?

By collecting patient-reported outcomes and long-term tracking data, the OBR aims to inform orthopedic practices and foster personalized treatment plans based on evidence.

Where can I find more information about AAOS initiatives?

Further details about AAOS initiatives and their impact on musculoskeletal health can be found on the official AAOS website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 261

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 305

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 210

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 156

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 460

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 272

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 278

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 220

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 256

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 213

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading

Top 5 Most Recently Viewed Articles

ANSI Electric Vehicles Standards Panel Releases New Report

Updated Category News Views 285

ANSI Electric Vehicles Standards Panel Releases New Report In a significant step towards enhancing the adoption of electric vehicles (EVs) and their infrastructure, the American National Standards Institute (ANSI) has unveiled the May 2025 Gaps Progress Report. This report is integral to understanding the collaborative efforts being made by various stakeholders to bridge...

Continue Reading
Oklahoma Startups Thrive in Catalyst Accelerator Boot Camp

Updated Category News Views 575

Catalyst Accelerator Empowers Startups through Innovative Boot Camp The Catalyst Accelerator is thrilled to unveil a significant opportunity for six emerging tech startups in Oklahoma. This new initiative, the Government Business Boot Camp, is fashioned to equip these talented companies with the insights and tools necessary to succeed in government contracting. In...

Continue Reading
Legal Action Commences for Biogen Inc. (NASDAQ: BIIB) Investors

Updated Category News Views 200

Legal Investigation for Biogen Inc. Stockholders Bragar Eagel & Squire, P.C., a reputable law firm, is currently investigating claims against Biogen Inc. (NASDAQ: BIIB) on behalf of long-term stockholders. This investigation follows the recent filing of a class action complaint aimed at holding the company accountable for alleged misleading statements regarding its...

Continue Reading
Understanding the Urgent Need for Data Governance in AI

Updated Category News Views 133

The Growing Importance of Data Governance in AI As the landscape of business evolves, the adoption of artificial intelligence (AI) in enterprises has surged, leading to significant transformations in operations, development, and knowledge work. However, this rapid integration of AI solutions has brought about new data risks that traditional technologies often overlook....

Continue Reading
Oracle's High Debt Levels Raise Concerns for Investors

Updated Category News Views 797

Oracle’s Debt Concerns Illuminate Financial Landscape In a recent analysis, a leading strategist from J.P. Morgan has drawn attention to the substantial debt levels of Oracle Corp. (NYSE: ORCL). Reporting a staggering 500% debt-to-equity ratio, Oracle’s financial commitments appear considerably higher when compared to other companies in the sector. Analysis from J.P....

Continue Reading